Literature DB >> 20876436

Pathophysiology of tricuspid regurgitation: quantitative Doppler echocardiographic assessment of respiratory dependence.

Yan Topilsky1, Christophe Tribouilloy, Hector I Michelena, Sorin Pislaru, Douglas W Mahoney, Maurice Enriquez-Sarano.   

Abstract

BACKGROUND: Respiratory dependence of tricuspid regurgitation (TR), a long-held concept suggested by murmur variation, remains unproven and of unclear mechanisms. METHODS AND
RESULTS: In 41 patients with mild or greater TR (median age, 67 years), we performed triple Doppler echocardiographic quantification (TR severity, right ventricular, and right atrial quantification) with simultaneous respirometer recording of respiratory phases. Expiration to inspiration changes (median) affected TR peak velocity (-40 cm/s; 25th to 75th percentile, -60 to -30 cm/s), duration (-12 milliseconds; 25th to 75th percentile, -45 to 2 milliseconds), and time-velocity integral (-17 cm; 25th to 75th percentile, -23.4 to -10 cm; all P<0.001), consistent with decreased TR driving force. Nevertheless, inspiratory TR augmentation was demonstrated by increased effective regurgitant orifice (0.21 cm(2); 25th to 75th percentile, 0.09 to 0.34 cm(2)) and volume (18 mL per beat; 25th to 75th percentile, 10 to 25 mL per beat; all P<0.001) infrequently detected clinically (2 of 41, 5). As a result of reduced TR driving force, regurgitant volume increased less than effective regurgitant orifice (120 [25th to 75th percentile, 78.6 to 169] versus 169 [ 25th to 75th percentile, 12.9 to 226.1]; P<0.001). During inspiration, right ventricular area increased (diastolic, 27.8 [25th to 75th percentile, 22.6 to 36.3] versus 26.5 [21.1 to 31.9]; P<0.0001) with widening of right ventricular shape (length-to-width ratio, 1.6 [ 25th to 75th percentile, 1.37 to 1.95] versus 1.7 [1.46 to 2.1]; P<0.0001), increased systolic annular diameter (P=0.003), valve tenting height (P<0.0001) and area (P<0.0001), and reduced valvular-to-annular ratio (P=0.006). Effective regurgitant orifice during inspiration was independently determined by inspiratory valvular-to-annular ratio (P=0.026) and inspiratory change in right ventricular length-to-width ratio (P=0.008) and valve tenting area (P=0.015).
CONCLUSIONS: TR is dynamic with almost universal respiratory changes of large magnitude and complex pathophysiology. During inspiration, a large increase in effective regurgitant orifice causes, despite a decline in regurgitant gradient, a notable increase in regurgitant volume. Effective regurgitant orifice changes are independently linked to inspiratory annular enlargement (decreased valvular coverage) and to inspiratory right ventricular shape widening with increased valvular tenting. These novel physiological insights into TR respiratory dependence underscore right-side heart plasticity and are important for clinical TR severity evaluation.

Entities:  

Mesh:

Year:  2010        PMID: 20876436     DOI: 10.1161/CIRCULATIONAHA.110.941310

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

Review 1.  Tricuspid regurgitation: pathophysiology and management.

Authors:  Rashmi Thapa; Buddhadeb Dawn; Jayant Nath
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

2.  Clinical and echocardiographic results of the Kalangos biodegradable tricuspid ring for moderate and severe functional tricuspid regurgitation treatment.

Authors:  Tugrul Goncu; Ihsan Alur; Arif Gucu; Erhan Tenekecioglu; Faruk Toktas; Nail Kahraman; Hakan Vural; Senol Yavuz
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Leaflet area as a determinant of tricuspid regurgitation severity in patients with pulmonary hypertension.

Authors:  Jonathan Afilalo; Julia Grapsa; Petros Nihoyannopoulos; Jonathan Beaudoin; J Simon R Gibbs; Richard N Channick; David Langleben; Lawrence G Rudski; Lanqi Hua; Mark D Handschumacher; Michael H Picard; Robert A Levine
Journal:  Circ Cardiovasc Imaging       Date:  2015-05       Impact factor: 7.792

4.  Indications for Surgery for Tricuspid Regurgitation.

Authors:  Yan Topilsky
Journal:  Interv Cardiol       Date:  2015-03

5.  Right heart chamber geometry and tricuspid annulus morphology in patients undergoing mitral valve repair with and without tricuspid valve annuloplasty.

Authors:  Gloria Tamborini; Laura Fusini; Manuela Muratori; Paola Gripari; Sarah Ghulam Ali; Cesare Fiorentini; Mauro Pepi
Journal:  Int J Cardiovasc Imaging       Date:  2016-01-28       Impact factor: 2.357

Review 6.  Tricuspid valve disease: diagnosis, prognosis and management of a rapidly evolving field.

Authors:  Lluis Asmarats; Maurizio Taramasso; Josep Rodés-Cabau
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

7.  Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.

Authors:  Philippe B Bertrand; Jessica R Overbey; Xin Zeng; Robert A Levine; Gorav Ailawadi; Michael A Acker; Peter K Smith; Vinod H Thourani; Emilia Bagiella; Marissa A Miller; Lopa Gupta; Michael J Mack; A Marc Gillinov; Gennaro Giustino; Alan J Moskowitz; Annetine C Gelijns; Michael E Bowdish; Patrick T O'Gara; James S Gammie; Judy Hung
Journal:  J Am Coll Cardiol       Date:  2021-02-16       Impact factor: 24.094

8.  Pulmonary acceleration time to optimize the timing of lung transplant in cystic fibrosis.

Authors:  Thibaud Damy; Pierre-Régis Burgel; Jean-Louis Pepin; Pierre-Yves Boelle; Claire Cracowski; Marlène Murris-Espin; Raphaele Nove-Josserand; Nathalie Stremler; Tabassome Simon; Serge Adnot; Brigitte Fauroux
Journal:  Pulm Circ       Date:  2012 Jan-Mar       Impact factor: 3.017

Review 9.  Revisit of Functional Tricuspid Regurgitation; Current Trends in the Diagnosis and Management.

Authors:  Denisa Muraru; Elena Surkova; Luigi Paolo Badano
Journal:  Korean Circ J       Date:  2016-07-21       Impact factor: 3.243

Review 10.  Secondary tricuspid valve regurgitation: a forgotten entity.

Authors:  Pilar Tornos Mas; José F Rodríguez-Palomares; Manuel J Antunes
Journal:  Heart       Date:  2015-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.